microRNA Replacement Therapy
SEC Filings

 
SEC Filings
Date Filed Filing Description View
08-04-17 10-Q quarterly report HTML PDF XLS XBRL Add to Briefcase
07-13-17 424B3 prospectus filed pursuant to rule 424 HTML PDF XLS Add to Briefcase
07-11-17 S-4/A registration statement HTML PDF XLS XBRL Add to Briefcase
06-29-17 SC 13G statement of beneficial ownership HTML PDF XLS Add to Briefcase
06-29-17 8-K current report HTML PDF XLS Add to Briefcase
06-21-17 S-4 registration statement HTML PDF XLS Add to Briefcase
06-09-17 425 other HTML PDF
Add to Briefcase
05-25-17 8-K current report HTML PDF XLS Add to Briefcase
05-23-17 SC 13D general statement of beneficial ownership HTML PDF XLS Add to Briefcase
05-19-17 425 other HTML PDF
Add to Briefcase
1
... NextLast
= add PDF file to Briefcase
© 2017 Mirna Therapeutics, Inc. All Rights Reserved.